OBJECTIVE: The purpose of this study was to determine whether quantitative pulmonary perfusion parameters obtained from 3D dynamic contrast-enhanced MR perfusion data can be used to assess the severity of primary pulmonary hypertension (PPH) as indicated by pulmonary vascular resistance (PVR) and mean pulmonary artery pressure (MPAP). CONCLUSION: Three-dimensional dynamic contrast-enhanced MRI has potential for assessment of disease severity as indicated by PVR and MPAP in patients with PPH.
OBJECTIVE: The purpose of this study was to determine whether quantitative pulmonary perfusion parameters obtained from 3D dynamic contrast-enhanced MR perfusion data can be used to assess the severity of primary pulmonary hypertension (PPH) as indicated by pulmonary vascular resistance (PVR) and mean pulmonary artery pressure (MPAP). CONCLUSION: Three-dimensional dynamic contrast-enhanced MRI has potential for assessment of disease severity as indicated by PVR and MPAP in patients with PPH.
Authors: Smitha Rajaram; Andrew J Swift; David Capener; Adam Telfer; Christine Davies; Catherine Hill; Robin Condliffe; Charles Elliot; Judith Hurdman; David G Kiely; Jim M Wild Journal: Eur Radiol Date: 2011-09-02 Impact factor: 5.315
Authors: F P Junqueira; C M A O Lima; A C Coutinho; D B Parente; L K Bittencourt; L G P Bessa; R C Domingues; E Marchiori Journal: Br J Radiol Date: 2012-08-29 Impact factor: 3.039
Authors: Frank G Zöllner; Gerald Weisser; Marcel Reich; Sven Kaiser; Stefan O Schoenberg; Steven P Sourbron; Lothar R Schad Journal: J Digit Imaging Date: 2013-04 Impact factor: 4.056